Pharma Firm Boehringer Ingelheim Plans to Expand in Mexico, an Industrial Info Market Brief
Pharma Firm Boehringer Ingelheim Plans to Expand in Mexico, an Industrial Info Market Brief
Pharmaceuticals company Boehringer Ingelheim expects to invest more than $50 million in its Xochimilco plant in Mexico, with the aim of increasing and improving production by its diabetes segment in the next three years. The company also plans to invest $25 million in its veterinary products plant in Guadalajara, with an expansion to be completed in 2021.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Japan's Pharma Industry Hosts $294 Million in Tablet-Manufacturing Projects
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...